Skip to main navigation Skip to search Skip to main content

A Randomized, Phase 1, Contemporaneously Controlled, Mutlicenter Study to Assess the Safety of PP007 in Subjects with Acute Ischemic Stroke (HEMERA-1)

Project: Research

Project Details

StatusFinished
Effective start/end date04/19/22 → 02/23/26

Funding

  • Prolong Pharmaceuticals: $21,150.00